Cynosure, the global leader in medical aesthetics, announced today the U.S. and Canadian launch of its ViaSure device to effectively treat the underlying causes, and not just the symptoms, of vascular-related sexual performance issues in men. Powered by the patented SoftWave technology, the ViaSure treatment safely and effectively increases blood flow and restores smooth muscle cells to bring back spontaneity and improve intimacy. The ViaSure treatment is a safe, effective, non-invasive alternative to traditional medication typically used to temporarily treat sexual performance issues. With ViaSure treatments there are no pills, no surgery, and no downtime.

"Studies show that 50 percent of men over the age of 50 will experience sexual dysfunction," said Todd Tillemans, Chief Executive Officer at Cynosure." With the ViaSure device, providers can safely and effectively treat the underlying causes of vascular-related sexual performance issues in men, helping to boost confidence. This is a game-changer for men's physical and emotional health, and we're looking forward to introducing our science-backed technology to a new audience of providers backed by industry-leading experts."

The ViaSure system is the only men's sexual health device with proprietary SoftWave technology featuring an applicator with a unique design to ensure optimal, consistent coverage and depth of shockwave energy. Upon delivery of the shockwave energy, a cellular response is triggered, activating the body's natural healing process, forming new blood vessels to increase blood flow and the proliferation of smooth muscle cells to restore tissue elasticity.

Read more at PR Newswire >>